ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,066.21
      0.95%
      US Tech 100
      17,077.20
      1.28%
      Dow Jones
      38,252.10
      0.92%
      Brent Oil
      83.735
      0.23%
      Bitcoin
      59,454.58
      2.09%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Alimera Sciences Inc (ALIM)

      7. Alimera Sciences Inc (ALIM) News

      ALIM

      Alimera Sciences (ALIM)

      Alimera Sciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ALIM
      DateTimeSourceHeadlineSymbolCompany
      2:07PMiHub NewswireFeaturedNanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
      04/30/20248:00AMGlobeNewswire Inc.Alimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate UpdateNASDAQ:ALIMAlimera Sciences Inc
      03/20/20248:00AMGlobeNewswire Inc.Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ALIMAlimera Sciences Inc
      03/19/20248:00AMGlobeNewswire Inc.Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina NetworkNASDAQ:ALIMAlimera Sciences Inc
      03/08/20245:23PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ALIMAlimera Sciences Inc
      03/07/20248:32AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALIMAlimera Sciences Inc
      03/07/20247:30AMGlobeNewswire Inc.Alimera Sciences Reports Fourth Quarter and Full Year 2023 ResultsNASDAQ:ALIMAlimera Sciences Inc
      02/29/20248:00AMGlobeNewswire Inc.Alimera Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024, and Provide Corporate UpdateNASDAQ:ALIMAlimera Sciences Inc
      02/13/20244:43PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ALIMAlimera Sciences Inc
      02/13/20244:24PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ALIMAlimera Sciences Inc
      02/13/20243:27PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ALIMAlimera Sciences Inc
      02/09/20245:25PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ALIMAlimera Sciences Inc
      02/09/20245:14PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ALIMAlimera Sciences Inc
      02/09/20245:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALIMAlimera Sciences Inc
      02/08/20248:00AMGlobeNewswire Inc.The UK National Institute for Health and Care Excellence (NICE) Issues Final Draft Guidance to Provide Patients with a Natural Lens (Phakic Eye) Being Treated for Chronic Diabetic Macular Edema Access to ILUVIEN®NASDAQ:ALIMAlimera Sciences Inc
      01/11/202412:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALIMAlimera Sciences Inc
      01/04/20244:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALIMAlimera Sciences Inc
      01/04/20244:02PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ALIMAlimera Sciences Inc
      01/04/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALIMAlimera Sciences Inc
      01/04/20248:00AMGlobeNewswire Inc.Alimera Completes Recruitment for the Synchronicity StudyNASDAQ:ALIMAlimera Sciences Inc
      01/02/20248:00AMGlobeNewswire Inc.Alimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ALIMAlimera Sciences Inc
      12/13/20235:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALIMAlimera Sciences Inc
      12/13/20235:19PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ALIMAlimera Sciences Inc
      12/12/20235:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALIMAlimera Sciences Inc
      12/12/20237:30AMGlobeNewswire Inc.Alimera Sciences Appoints Todd Wood as President of U.S. Operations and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ALIMAlimera Sciences Inc
      11/28/20234:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALIMAlimera Sciences Inc
      11/28/20234:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALIMAlimera Sciences Inc
      11/28/20234:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALIMAlimera Sciences Inc
      11/08/20236:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALIMAlimera Sciences Inc
      11/08/20236:54PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ALIMAlimera Sciences Inc
       Showing the most relevant articles for your search:NASDAQ:ALIM